Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

HSIC vs CAH vs MCK vs OMI

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
HSIC
Henry Schein, Inc.

Medical - Distribution

HealthcareNASDAQ • US
Market Cap$8.09B
5Y Perf.+16.1%
CAH
Cardinal Health, Inc.

Medical - Distribution

HealthcareNYSE • US
Market Cap$43.59B
5Y Perf.+238.7%
MCK
McKesson Corporation

Medical - Distribution

HealthcareNYSE • US
Market Cap$92.15B
5Y Perf.+374.1%
OMI
Owens & Minor, Inc.

Medical - Distribution

HealthcareNYSE • US
Market Cap$171M
5Y Perf.-72.1%

HSIC vs CAH vs MCK vs OMI — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
HSIC logoHSIC
CAH logoCAH
MCK logoMCK
OMI logoOMI
IndustryMedical - DistributionMedical - DistributionMedical - DistributionMedical - Distribution
Market Cap$8.09B$43.59B$92.15B$171M
Revenue (TTM)$13.18B$250.55B$403.43B$2.76B
Net Income (TTM)$398M$1.56B$4.76B$-1.10B
Gross Margin29.1%3.7%3.6%
Operating Margin5.8%0.9%1.5%1.0%
Forward P/E13.3x17.9x19.3x2.3x
Total Debt$3.69B$9.35B$7.39B$320M
Cash & Equiv.$156M$3.87B$5.69B$282M

HSIC vs CAH vs MCK vs OMILong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

HSIC
CAH
MCK
OMI
StockMay 20May 26Return
Henry Schein, Inc. (HSIC)100116.1+16.1%
Cardinal Health, In… (CAH)100338.7+238.7%
McKesson Corporation (MCK)100474.1+374.1%
Owens & Minor, Inc. (OMI)10027.9-72.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: HSIC vs CAH vs MCK vs OMI

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CAH and MCK are tied at the top with 3 categories each — the right choice depends on your priorities. McKesson Corporation is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. HSIC also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
HSIC
Henry Schein, Inc.
The Quality Compounder

HSIC is the clearest fit if your priority is quality.

  • 3.0% margin vs OMI's -39.8%
Best for: quality
CAH
Cardinal Health, Inc.
The Income Pick

CAH carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.

  • Dividend streak 20 yrs, beta 0.03, yield 1.1%
  • Lower volatility, beta 0.03, current ratio 0.94x
  • Beta 0.03, yield 1.1%, current ratio 0.94x
  • Beta 0.03 vs OMI's 1.44
Best for: income & stability and sleep-well-at-night
MCK
McKesson Corporation
The Growth Play

MCK is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.

  • Rev growth 16.2%, EPS growth 14.9%, 3Y rev CAGR 10.8%
  • 348.1% 10Y total return vs CAH's 160.8%
  • PEG 0.49 vs HSIC's 4.21
  • 16.2% revenue growth vs OMI's -74.2%
Best for: growth exposure and long-term compounding
OMI
Owens & Minor, Inc.
The Value Angle

OMI lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
See the full category breakdown
CategoryWinnerWhy
GrowthMCK logoMCK16.2% revenue growth vs OMI's -74.2%
ValueMCK logoMCKBetter valuation composite
Quality / MarginsHSIC logoHSIC3.0% margin vs OMI's -39.8%
Stability / SafetyCAH logoCAHBeta 0.03 vs OMI's 1.44
DividendsCAH logoCAH1.1% yield, 20-year raise streak, vs MCK's 0.4%, (2 stocks pay no dividend)
Momentum (1Y)CAH logoCAH+22.0% vs OMI's -71.1%
Efficiency (ROA)MCK logoMCK5.7% ROA vs OMI's -44.9%, ROIC 5.4% vs 1.8%

HSIC vs CAH vs MCK vs OMI — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

HSICHenry Schein, Inc.
FY 2018
Healthcare Distribution
96.1%$12.7B
Technology
3.9%$509M
CAHCardinal Health, Inc.
FY 2025
Pharmaceutical Member
91.9%$204.6B
GMPD
5.7%$12.6B
Other Operating Segment
2.4%$5.4B
MCKMcKesson Corporation
FY 2025
U.S. Pharmaceutical Segment
91.3%$327.7B
International Segment
4.1%$14.7B
Medical-Surgical Solutions Segment
3.2%$11.4B
Prescription Technology Solutions
1.5%$5.2B
OMIOwens & Minor, Inc.
FY 2025
Diabetes Product
56.9%$783M
Product and Service, Other
20.9%$288M
Wound Care
13.7%$189M
Urology
8.4%$116M

HSIC vs CAH vs MCK vs OMI — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCAHLAGGINGOMI

Income & Cash Flow (Last 12 Months)

HSIC leads this category, winning 4 of 6 comparable metrics.

MCK is the larger business by revenue, generating $403.4B annually — 146.1x OMI's $2.8B. HSIC is the more profitable business, keeping 3.0% of every revenue dollar as net income compared to OMI's -39.8%. On growth, CAH holds the edge at +11.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricHSIC logoHSICHenry Schein, Inc.CAH logoCAHCardinal Health, …MCK logoMCKMcKesson Corporat…OMI logoOMIOwens & Minor, In…
RevenueTrailing 12 months$13.2B$250.5B$403.4B$2.8B
EBITDAEarnings before interest/tax$1.1B$3.2B$6.8B$277M
Net IncomeAfter-tax profit$398M$1.6B$4.8B-$1.1B
Free Cash FlowCash after capex$561M$4.4B$6.0B-$353M
Gross MarginGross profit ÷ Revenue+29.1%+3.7%+3.6%
Operating MarginEBIT ÷ Revenue+5.8%+0.9%+1.5%+1.0%
Net MarginNet income ÷ Revenue+3.0%+0.6%+1.2%-39.8%
FCF MarginFCF ÷ Revenue+4.3%+1.8%+1.5%-12.8%
Rev. Growth (YoY)Latest quarter vs prior year+7.7%+11.0%+6.0%-146.3%
EPS Growth (YoY)Latest quarter vs prior year+14.9%-19.5%+37.0%+4.5%
HSIC leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

OMI leads this category, winning 4 of 6 comparable metrics.

At 21.6x trailing earnings, HSIC trades at a 26% valuation discount to MCK's 29.2x P/E. Adjusting for growth (PEG ratio), MCK offers better value at 0.75x vs HSIC's 6.84x — a lower PEG means you pay less per unit of expected earnings growth.

MetricHSIC logoHSICHenry Schein, Inc.CAH logoCAHCardinal Health, …MCK logoMCKMcKesson Corporat…OMI logoOMIOwens & Minor, In…
Market CapShares × price$8.1B$43.6B$92.1B$171M
Enterprise ValueMkt cap + debt − cash$11.6B$49.1B$93.8B$209M
Trailing P/EPrice ÷ TTM EPS21.56x28.72x29.25x-0.16x
Forward P/EPrice ÷ next-FY EPS est.13.26x17.94x19.28x2.31x
PEG RatioP/E ÷ EPS growth rate6.84x0.75x
EV / EBITDAEnterprise value multiple10.87x16.01x18.74x1.70x
Price / SalesMarket cap ÷ Revenue0.61x0.20x0.26x0.06x
Price / BookPrice ÷ Book value/share1.79x
Price / FCFMarket cap ÷ FCF14.12x23.56x17.63x
OMI leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

MCK leads this category, winning 5 of 8 comparable metrics.

MCK delivers a 3.0% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-21 for OMI. On the Piotroski fundamental quality scale (0–9), CAH scores 6/9 vs OMI's 2/9, reflecting solid financial health.

MetricHSIC logoHSICHenry Schein, Inc.CAH logoCAHCardinal Health, …MCK logoMCKMcKesson Corporat…OMI logoOMIOwens & Minor, In…
ROE (TTM)Return on equity+8.2%+3.0%-21.1%
ROA (TTM)Return on assets+3.6%+2.8%+5.7%-44.9%
ROICReturn on invested capital+7.1%+33.8%+5.4%+1.8%
ROCEReturn on capital employed+9.8%+19.2%+30.5%+1.3%
Piotroski ScoreFundamental quality 0–94662
Debt / EquityFinancial leverage0.77x
Net DebtTotal debt minus cash$3.5B$5.5B$1.7B$38M
Cash & Equiv.Liquid assets$156M$3.9B$5.7B$282M
Total DebtShort + long-term debt$3.7B$9.3B$7.4B$320M
Interest CoverageEBIT ÷ Interest expense4.59x6.38x33.79x-0.12x
MCK leads this category, winning 5 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

CAH leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in MCK five years ago would be worth $38,689 today (with dividends reinvested), compared to $655 for OMI. Over the past 12 months, CAH leads with a +22.0% total return vs OMI's -71.1%. The 3-year compound annual growth rate (CAGR) favors CAH at 31.5% vs OMI's -49.9% — a key indicator of consistent wealth creation.

MetricHSIC logoHSICHenry Schein, Inc.CAH logoCAHCardinal Health, …MCK logoMCKMcKesson Corporat…OMI logoOMIOwens & Minor, In…
YTD ReturnYear-to-date-8.2%-9.5%-8.5%-3.4%
1-Year ReturnPast 12 months+5.9%+22.0%+4.6%-71.1%
3-Year ReturnCumulative with dividends-11.7%+127.3%+106.4%-87.4%
5-Year ReturnCumulative with dividends-12.5%+235.7%+286.9%-93.5%
10-Year ReturnCumulative with dividends+5.3%+160.8%+348.1%-86.2%
CAGR (3Y)Annualised 3-year return-4.0%+31.5%+27.3%-49.9%
CAH leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

CAH leads this category, winning 2 of 2 comparable metrics.

CAH is the less volatile stock with a 0.03 beta — it tends to amplify market swings less than OMI's 1.44 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CAH currently trades 79.3% from its 52-week high vs OMI's 23.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricHSIC logoHSICHenry Schein, Inc.CAH logoCAHCardinal Health, …MCK logoMCKMcKesson Corporat…OMI logoOMIOwens & Minor, In…
Beta (5Y)Sensitivity to S&P 5000.73x0.03x0.04x1.44x
52-Week HighHighest price in past year$89.29$233.60$999.00$9.55
52-Week LowLowest price in past year$61.95$137.75$637.00$1.84
% of 52W HighCurrent price vs 52-week peak+79.0%+79.3%+75.3%+23.5%
RSI (14)Momentum oscillator 0–10039.133.216.246.5
Avg Volume (50D)Average daily shares traded1.2M1.7M757K690K
CAH leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

CAH leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: HSIC as "Hold", CAH as "Buy", MCK as "Buy", OMI as "Hold". Consensus price targets imply 78.6% upside for OMI (target: $4) vs 22.6% for HSIC (target: $86). For income investors, CAH offers the higher dividend yield at 1.10% vs MCK's 0.36%.

MetricHSIC logoHSICHenry Schein, Inc.CAH logoCAHCardinal Health, …MCK logoMCKMcKesson Corporat…OMI logoOMIOwens & Minor, In…
Analyst RatingConsensus buy/hold/sellHoldBuyBuyHold
Price TargetConsensus 12-month target$86.43$249.67$1006.50$4.00
# AnalystsCovering analysts32333110
Dividend YieldAnnual dividend ÷ price+1.1%+0.4%
Dividend StreakConsecutive years of raises120170
Dividend / ShareAnnual DPS$2.04$2.69
Buyback YieldShare repurchases ÷ mkt cap+10.5%+1.8%+3.4%0.0%
CAH leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

CAH leads in 3 of 6 categories (Total Returns, Risk & Volatility). HSIC leads in 1 (Income & Cash Flow).

Best OverallCardinal Health, Inc. (CAH)Leads 3 of 6 categories
Loading custom metrics...

HSIC vs CAH vs MCK vs OMI: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is HSIC or CAH or MCK or OMI a better buy right now?

For growth investors, McKesson Corporation (MCK) is the stronger pick with 16.

2% revenue growth year-over-year, versus -74. 2% for Owens & Minor, Inc. (OMI). Henry Schein, Inc. (HSIC) offers the better valuation at 21. 6x trailing P/E (13. 3x forward), making it the more compelling value choice. Analysts rate Cardinal Health, Inc. (CAH) a "Buy" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — HSIC or CAH or MCK or OMI?

On trailing P/E, Henry Schein, Inc.

(HSIC) is the cheapest at 21. 6x versus McKesson Corporation at 29. 2x. On forward P/E, Owens & Minor, Inc. is actually cheaper at 2. 3x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: McKesson Corporation wins at 0. 49x versus Henry Schein, Inc. 's 4. 21x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — HSIC or CAH or MCK or OMI?

Over the past 5 years, McKesson Corporation (MCK) delivered a total return of +286.

9%, compared to -93. 5% for Owens & Minor, Inc. (OMI). Over 10 years, the gap is even starker: MCK returned +348. 1% versus OMI's -86. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — HSIC or CAH or MCK or OMI?

By beta (market sensitivity over 5 years), Cardinal Health, Inc.

(CAH) is the lower-risk stock at 0. 03β versus Owens & Minor, Inc. 's 1. 44β — meaning OMI is approximately 4160% more volatile than CAH relative to the S&P 500.

05

Which is growing faster — HSIC or CAH or MCK or OMI?

By revenue growth (latest reported year), McKesson Corporation (MCK) is pulling ahead at 16.

2% versus -74. 2% for Owens & Minor, Inc. (OMI). On earnings-per-share growth, the picture is similar: Cardinal Health, Inc. grew EPS 87. 0% year-over-year, compared to -201. 1% for Owens & Minor, Inc.. Over a 3-year CAGR, MCK leads at 10. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — HSIC or CAH or MCK or OMI?

Henry Schein, Inc.

(HSIC) is the more profitable company, earning 3. 0% net margin versus -39. 8% for Owens & Minor, Inc. — meaning it keeps 3. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HSIC leads at 5. 7% versus 1. 0% for OMI. At the gross margin level — before operating expenses — HSIC leads at 29. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is HSIC or CAH or MCK or OMI more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, McKesson Corporation (MCK) is the more undervalued stock at a PEG of 0. 49x versus Henry Schein, Inc. 's 4. 21x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Owens & Minor, Inc. (OMI) trades at 2. 3x forward P/E versus 19. 3x for McKesson Corporation — 17. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OMI: 78. 6% to $4. 00.

08

Which pays a better dividend — HSIC or CAH or MCK or OMI?

In this comparison, CAH (1.

1% yield), MCK (0. 4% yield) pay a dividend. HSIC, OMI do not pay a meaningful dividend and should not be held primarily for income.

09

Is HSIC or CAH or MCK or OMI better for a retirement portfolio?

For long-horizon retirement investors, Cardinal Health, Inc.

(CAH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 03), 1. 1% yield, +160. 8% 10Y return). Both have compounded well over 10 years (CAH: +160. 8%, OMI: -86. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between HSIC and CAH and MCK and OMI?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: HSIC is a small-cap quality compounder stock; CAH is a mid-cap quality compounder stock; MCK is a mid-cap high-growth stock; OMI is a small-cap quality compounder stock. CAH pays a dividend while HSIC, MCK, OMI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

HSIC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 17%
Run This Screen
Stocks Like

CAH

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

MCK

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

OMI

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform HSIC and CAH and MCK and OMI on the metrics below

Revenue Growth>
%
(HSIC: 7.7% · CAH: 11.0%)
P/E Ratio<
x
(HSIC: 21.6x · CAH: 28.7x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.